EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A re‐assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight

Pedro Mercader-García iD, Juan Francisco Silvestre iD, Francisco Jose Navarro-Triviño iD, Ana María Giménez-Arnau iD, María Antonia Pastor-Nieto iD, Susana Cordoba-Guijarro iD, Gemma Melé-Ninot iD, Fátima Tous-Romero iD, Ricardo González-Pérez iD, Inmaculada Ruiz-González, Javier Sánchez-Pérez iD, María Elena Gática-Ortega iD und 10 weitere

Contact Dermatitis · 2024

DOI: 10.1111/cod.14639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contact Dermatitis, 2024. Verfasst von Pedro Mercader-García und 21 weiteren Autor:innen. Beteiligte Einrichtung: Hospital General Universitario Morales Meseguer, Universidad de Murcia, Murcia, Spain. Hauptthemen laut MEDLINE: Clobetasol, Dermatitis, Allergic Contact, Budesonide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Sanidad, Politica Social e Igualdad, Ministerio de Sanidad, Consumo y Bienestar Social.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Budesonide and tixocortol pivalate as markers of contact allergy to corticosteroids have been questioned, as they are not able to detect a significant percentage of allergic patients.

Objectives

To investigate the potential role of clobetasol propionate in enhancing corticosteroid sensitisation detection.

Methods

Between January 2022 and December 2023, patients who attended centres involved in the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy were tested with an extended baseline series that included budesonide, tixocortol pivalate, clobetasol propionate 0.1% in ethanol and 1% in petrolatum.

Results

A total of 4338 patients were tested. Twenty‐four patients were allergic to budesonide (0.55%, 95% CI: 0.37–0.82); nine patients were allergic to tixocortol pivalate (0.21%, 95% CI: 0.11–0.39); and 23 patients were allergic to clobetasol (0.53%, 95% CI: 0.35–0.79). Only four of those patients allergic to clobetasol were detected by budesonide and one by tixocortol pivalate. No significant differences in the number of positive tests were found between clobetasol in petrolatum or ethanol.

Conclusions

In Spain budesonide remains the main corticosteroid allergy marker whereas the role of tixocortol pivalate is questionable. The addition of clobetasol propionate to the Spanish baseline series would improve the ability to detect patients allergic to corticosteroids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClobetasolDermatitis, Allergic ContactBudesonideHumansSpainFemaleMalePatch TestsAdultMiddle AgedGlucocorticoidsHydrocortisone

Stichwörter der Autor:innen

budesonideclobetasol propionatecontact dermatitistixocortol pivalate

Substanzen

ClobetasolBudesonidetixocortol pivalateGlucocorticoidsHydrocortisone

Autor:innen und Institutionen

  • Hospital General Universitario Morales Meseguer, Universidad de Murcia, Murcia, Spain.
  • Dermatology Department, Hospital General Universitario Dr. Balmis, Alicante, Spain.
  • Dermatology Department, Hospital Universitario San Cecilio, Granada, Spain.
  • Dermatology Department, Hospital del Mar-IMIM, Barcelona, Spain.
  • Dermatology Department, Fundación Jimenez Diaz, Madrid, Spain.
  • Dermatology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain.

ORCID-Profile: Pedro Mercader-García, Juan Francisco Silvestre, Francisco Jose Navarro-Triviño, Ana María Giménez-Arnau, María Antonia Pastor-Nieto, Susana Cordoba-Guijarro, Gemma Melé-Ninot, Fátima Tous-Romero, Ricardo González-Pérez, Javier Sánchez-Pérez, María Elena Gática-Ortega, Paloma Sánchez-Pedreño, Javier Miquel-Miquel, Javier Ortiz-Frutos, Jose Manuel Carrascosa, Esther Serra-Baldrich, Tatiana Sanz-Sánchez, Victoriano Soria-Aledo, Andrés Carrillo, Leopoldo Borrego

Förderung

  • Ministerio de Sanidad, Politica Social e Igualdad
  • Ministerio de Sanidad, Consumo y Bienestar Social

Zitieren

APA

Mercader-García, P., Silvestre, J. F., Navarro-Triviño, F. J., Giménez-Arnau, A. M., Pastor-Nieto, M. A., Cordoba-Guijarro, S., Melé-Ninot, G., Tous-Romero, F., González-Pérez, R., Ruiz-González, I., Sánchez-Pérez, J., Gática-Ortega, M. E., Sánchez-Pedreño, P., Miquel-Miquel, J., Ortiz-Frutos, J., Carrascosa, J. M., Serra-Baldrich, E., Sanz-Sánchez, T., Soria-Aledo, V., …, & REIDAC (2024). A re‐assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight. Contact Dermatitis. https://doi.org/10.1111/cod.14639

Vancouver

Mercader-García P, Silvestre JF, Navarro-Triviño FJ, Giménez-Arnau AM, Pastor-Nieto MA, Cordoba-Guijarro S, et al. A re‐assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight. Contact Dermatitis. 2024. doi:10.1111/cod.14639

BibTeX
@article{MercaderGarca2024,
  author = {Mercader-García, Pedro and Silvestre, Juan Francisco and Navarro-Triviño, Francisco Jose and Giménez-Arnau, Ana María and Pastor-Nieto, María Antonia and Cordoba-Guijarro, Susana and Melé-Ninot, Gemma and Tous-Romero, Fátima and González-Pérez, Ricardo and Ruiz-González, Inmaculada and Sánchez-Pérez, Javier and Gática-Ortega, María Elena and Sánchez-Pedreño, Paloma and Miquel-Miquel, Javier and Ortiz-Frutos, Javier and Carrascosa, Jose Manuel and Serra-Baldrich, Esther and Sanz-Sánchez, Tatiana and Soria-Aledo, Victoriano and Carrillo, Andrés and Borrego, Leopoldo and REIDAC, REIDAC},
  title = {A re‐assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight},
  journal = {Contact Dermatitis},
  year = {2024},
  doi = {10.1111/cod.14639}
}
Kostenlos starten →